NCT07086456
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Sun yat-sen University Cancer Center Guangzhou, Guangdong, China
Clinical trial condition
Concurrent Chemoradiotherapy
Explore clinical trials studying Concurrent Chemoradiotherapy. Study availability and eligibility vary by location and protocol.
8 public trials
4 recruiting studies
Concurrent Chemoradiotherapy trial results
NCT06734702
- Conditions
- Concurrent Chemoradiotherapy, Immunotherapy, Locally Advanced Non-Small Cell Lung Cancer, +1 more
- Locations
-
- Sun yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT06288373
- Conditions
- Cervical Cancer, Concurrent Chemoradiotherapy, Female Urogenital Diseases, +14 more
- Locations
-
- Anhui Provincial Cancer Hospital Hefei, Anhui, China
- Beiing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
- The First Affiliated Hospital (Southwest Hospital), Army Medical University (Third Military Medical University) Chongqing, Chongqing Municipality, China
- Gansu Provincial Maternity and Child-care Hospital Lanzhou, Gansu, China
NCT06391190
- Conditions
- Concurrent Chemoradiotherapy, Immunotherapy, Locally Advanced Cervical Carcinoma
- Locations
-
- RenJi hospital Shanghai, China
NCT05944809
- Conditions
- Blood Platelet Disorders, Concurrent Chemoradiotherapy, Cytopenia, +14 more
- Locations
-
- Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, Beijing Municipality, China
Completed
CCRT for Esophageal Cancer.
NCT02607982
- Conditions
- Concurrent Chemoradiotherapy, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
Not specified
Active, Not Recruiting
Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)
NCT05621707
- Conditions
- Chemotherapy, Concurrent Chemoradiotherapy, Digestive System Diseases, +10 more
- Locations
-
- Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
Active, Not Recruiting
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
NCT06342167
- Conditions
- Concurrent Chemoradiotherapy, Immunonutrition, Locally Advanced Esophageal Squamous Cell Carcinoma, +2 more
- Locations
-
- Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, Beijing Municipality, China
- Department of Radiation Oncology，Clinical Oncology School of Fujian Medical University，Fujian Cancer Hospital Fujian, China
- Department of Oncology, Affiliated Hospital, Hebei University of Engineering Handan, Hebei, China
- Department 1st of Radiation Oncology, Anyang Tumor Hospital Anyang, Henan, China